GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » EV-to-EBITDA

CBSTF (Cannabist Company Holdings) EV-to-EBITDA : 25.99 (As of Jun. 30, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabist Company Holdings's enterprise value is $466.6 Mil. Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $18.0 Mil. Therefore, Cannabist Company Holdings's EV-to-EBITDA for today is 25.99.

The historical rank and industry rank for Cannabist Company Holdings's EV-to-EBITDA or its related term are showing as below:

CBSTF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.34   Med: -9.55   Max: 153.52
Current: 25.99

During the past 7 years, the highest EV-to-EBITDA of Cannabist Company Holdings was 153.52. The lowest was -81.34. And the median was -9.55.

CBSTF's EV-to-EBITDA is ranked worse than
77.64% of 729 companies
in the Drug Manufacturers industry
Industry Median: 13.83 vs CBSTF: 25.99

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-30), Cannabist Company Holdings's stock price is $0.0465. Cannabist Company Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.224. Therefore, Cannabist Company Holdings's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Cannabist Company Holdings EV-to-EBITDA Historical Data

The historical data trend for Cannabist Company Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings EV-to-EBITDA Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial -17.16 -21.61 93.55 16.12 16.42

Cannabist Company Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.28 11.46 5.72 16.42 31.29

Competitive Comparison of Cannabist Company Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's EV-to-EBITDA falls into.


;
;

Cannabist Company Holdings EV-to-EBITDA Calculation

Cannabist Company Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=466.605/17.954
=25.99

Cannabist Company Holdings's current Enterprise Value is $466.6 Mil.
Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (OTCPK:CBSTF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cannabist Company Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0465/-0.224
=At Loss

Cannabist Company Holdings's share price for today is $0.0465.
Cannabist Company Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.224.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Cannabist Company Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Executives
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202